There is an increase in the number of B7-H3 positive cells in GBM in comparison to non-cancerous tissues (GBM: 33.3% B7-H3+ cells vs non-cancerous: 7.2% B7-H3+ cells) (Fig. 1d, e). This evidence concerns the gene CD276 and glioblastoma.